 "Dr Reddy's")
Drug major Dr Reddy's Laboratories Limited has reported a 45 per cent jump in net profit at Rs 485.2 crore for the quarter ended December, 2018 due to lower base and lower tax outgo as compared to Rs 334.4 crore in the corresponding quarter previous year.
It may be recalled that the company's net profit had declined 29 per cent in the year ago period.
Despite 8 per cent revenue decline in the US, which is its largest market, Dr Reddy's has managed to increase the overall revenues by 1 percent at Rs 3,850 crore for the third quarter helped by a
